Yinggang Zou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yinggang Zou has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Xiaoyan Yu
School of Pharmaceutical Sciences, Jilin University
3 shared publicationsGuihua Zhou
Heersink School of Medicine, University of Alabama at Birmingham
2 shared publicationsLianwen Zheng
Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, China
2 shared publicationsMin Wang
The Reproductive Medical Center, China-Japan Union Hospital of Jilin University
2 shared publicationsShuai Ma
Department of Obstetrics and Gynecology, The Second Hospital of Jilin University
2 shared publications- Xiaoyan Yu
Department of Experimental Pharmacology and Toxicology, School of Pharmacy, Jilin University, Changchun 130021, China
2 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1867408
Microplastics and female infertility: reproductive toxicity and underlying mechanisms
In modern society, the progression of ovarian aging in women has accelerated, and the incidence of infertility has increased markedly with a distinct younger-onset trend. Exploring the etiology and pathogenesis of infertility has become a core research focus for clinicians. Plastic products bring tremendous convenience to modern life, while the health risks caused by plastic pollution have aroused global concern. As typical endocrine-disrupting chemicals, microplastics (MPs) can enter the human body through dietary intake, respiration, and skin contact, and accumulate in multiple organs. Accumulated MPs impair the physiological function of the female reproductive system and are closely associated with multiple gynecological disorders, including polycystic ovary syndrome, endometriosis, and premature ovarian insufficiency. After internalization, MPs trigger a series of pathological events such as epigenetic alterations, hormonal metabolism disturbance, inflammatory response, immune dysregulation, oxidative stress, and cellular damage, ultimately resulting in female reproductive impairment. The exposure routes and pathogenic mechanisms underlying MPs-induced reproductive toxicity have emerged as critical scientific issues that urgently require addressing. From an innovative perspective, this review elaborates on the mechanisms underlying the occurrence and progression of female infertility-related diseases mediated by MPs. It aims to provide novel insights for the clinical diagnosis and treatment of female infertility, offer theoretical references for pre-pregnancy counseling and reproductive health management, and supply scientific evidence for the precise prevention and control of MP pollution.
- 3 August 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1867408
Open AccessMicroplastics and female infertility: reproductive toxicity and underlying mechanisms
In modern society, the progression of ovarian aging in women has accelerated, and the incidence of infertility has increased markedly with a distinct younger-onset trend. Exploring the etiology and pathogenesis of infertility has become a core research focus for clinicians. Plastic products bring tremendous convenience to modern life, while the health risks caused by plastic pollution have aroused global concern. As typical endocrine-disrupting chemicals, microplastics (MPs) can enter the human body through dietary intake, respiration, and skin contact, and accumulate in multiple organs. Accumulated MPs impair the physiological function of the female reproductive system and are closely associated with multiple gynecological disorders, including polycystic ovary syndrome, endometriosis, and premature ovarian insufficiency. After internalization, MPs trigger a series of pathological events such as epigenetic alterations, hormonal metabolism disturbance, inflammatory response, immune dysregulation, oxidative stress, and cellular damage, ultimately resulting in female reproductive impairment. The exposure routes and pathogenic mechanisms underlying MPs-induced reproductive toxicity have emerged as critical scientific issues that urgently require addressing. From an innovative perspective, this review elaborates on the mechanisms underlying the occurrence and progression of female infertility-related diseases mediated by MPs. It aims to provide novel insights for the clinical diagnosis and treatment of female infertility, offer theoretical references for pre-pregnancy counseling and reproductive health management, and supply scientific evidence for the precise prevention and control of MP pollution.
- Open Access
- 6 May 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (5) , 587
Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms, Current Treatment and Therapeutic Potential of Plant Antioxidants
Diabetic cardiomyopathy (DCM), one of the most severe complications of diabetes, is closely associated with oxidative stress (OS) in its development and progression. Studies have shown that plant antioxidants play an important role in the prevention and treatment of DCM by modulating redox signaling and regulating the sources of reactive oxygen species (ROS) generation. However, most existing evidence comes from animal and cellular experiments, and clinical data are limited. In addition, their clinical application faces challenges, including poor bioavailability and difficulty in standardizing active ingredients. Therefore, this review focuses on the role of plant antioxidants in regulating myocardial oxidative stress and maintaining redox homeostasis, and explores their potential clinical applications and current limitations. This review aims to provide a theoretical basis and guidance for the prevention and treatment of DCM using plant antioxidants.
- 6 May 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (5) , 587
Open AccessOxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms, Current Treatment and Therapeutic Potential of Plant Antioxidants
Diabetic cardiomyopathy (DCM), one of the most severe complications of diabetes, is closely associated with oxidative stress (OS) in its development and progression. Studies have shown that plant antioxidants play an important role in the prevention and treatment of DCM by modulating redox signaling and regulating the sources of reactive oxygen species (ROS) generation. However, most existing evidence comes from animal and cellular experiments, and clinical data are limited. In addition, their clinical application faces challenges, including poor bioavailability and difficulty in standardizing active ingredients. Therefore, this review focuses on the role of plant antioxidants in regulating myocardial oxidative stress and maintaining redox homeostasis, and explores their potential clinical applications and current limitations. This review aims to provide a theoretical basis and guidance for the prevention and treatment of DCM using plant antioxidants.
- Open Access
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1795152
Microecological modulators—new perspectives for treating sex hormone disorders
Sex hormone related disorders, characterized by complex etiology and long-term health risks, pose a significant challenge to global health. Hormone-based therapies are often accompanied by adverse effects and fail to address the underlying pathophysiological mechanisms. The “gut microbiota-sex hormone axis” maintains endocrine homeostasis through diverse pathways, including enzymatic reactions, immune modulation, metabolic regulation, and the microbiome-gut-brain axis. Dysregulation of this axis has been identified as a critical factor in the pathogenesis of sex hormone-related disorders. Probiotics have emerged as a promising adjunctive therapeutic strategy by targeting this axis. Preclinical and clinical studies have demonstrated that specific probiotic strains ameliorate hormonal imbalances, attenuate inflammation, and optimize metabolic parameters, showing positive efficacy in sex hormone-related disorders. This review systematically elaborates the regulatory mechanisms of this bidirectional axis and highlights the application of probiotics and its regulatory roles as targeted interventions in related disorders.
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1795152
Open AccessMicroecological modulators—new perspectives for treating sex hormone disorders
Sex hormone related disorders, characterized by complex etiology and long-term health risks, pose a significant challenge to global health. Hormone-based therapies are often accompanied by adverse effects and fail to address the underlying pathophysiological mechanisms. The “gut microbiota-sex hormone axis” maintains endocrine homeostasis through diverse pathways, including enzymatic reactions, immune modulation, metabolic regulation, and the microbiome-gut-brain axis. Dysregulation of this axis has been identified as a critical factor in the pathogenesis of sex hormone-related disorders. Probiotics have emerged as a promising adjunctive therapeutic strategy by targeting this axis. Preclinical and clinical studies have demonstrated that specific probiotic strains ameliorate hormonal imbalances, attenuate inflammation, and optimize metabolic parameters, showing positive efficacy in sex hormone-related disorders. This review systematically elaborates the regulatory mechanisms of this bidirectional axis and highlights the application of probiotics and its regulatory roles as targeted interventions in related disorders.
- Open Access
- 16 December 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1734367
Pathogenic mechanisms and therapeutic potential of the microbiome in premature ovarian insufficiency
The postponement of childbearing age has become a global issue. Factors such as increased work pressures on women and environmental changes have led to a rising incidence and younger onset of premature ovarian insufficiency (POI). POI not only impacts patients’ reproductive function but also heightens the risk of depression, anxiety, cognitive decline, premature mortality, osteoporosis, and cardiovascular disease. Exploring effective prevention and treatment strategies for POI can slow ovarian ageing and safeguard female reproductive health. Microbiome research confirms that most human tissues and organs form dynamic, interactive systems with symbiotic microbes that play a crucial role in female reproductive function. Previous studies on the microbiome and female reproductive health have rarely focused on POI. The proposed ‘Microbiota-Ovary Axis’ aims to establish an integrated regulatory framework. This theoretical model systematically elucidates how microbial signals influence ovarian function through four core pathways: the hypothalamic-pituitary-ovarian (HPO) axis, metabolism and endocrine regulation, immunoregulation, and oxidative stress. Evaluating the efficacy of dietary modifications, probiotics, and microbiota transplantation in animal models and preliminary clinical studies will establish a robust theoretical foundation for developing microbiota-targeted innovative diagnostic and therapeutic strategies for POI, thereby enhancing reproductive health throughout the female lifespan.
- 16 December 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1734367
Open AccessPathogenic mechanisms and therapeutic potential of the microbiome in premature ovarian insufficiency
The postponement of childbearing age has become a global issue. Factors such as increased work pressures on women and environmental changes have led to a rising incidence and younger onset of premature ovarian insufficiency (POI). POI not only impacts patients’ reproductive function but also heightens the risk of depression, anxiety, cognitive decline, premature mortality, osteoporosis, and cardiovascular disease. Exploring effective prevention and treatment strategies for POI can slow ovarian ageing and safeguard female reproductive health. Microbiome research confirms that most human tissues and organs form dynamic, interactive systems with symbiotic microbes that play a crucial role in female reproductive function. Previous studies on the microbiome and female reproductive health have rarely focused on POI. The proposed ‘Microbiota-Ovary Axis’ aims to establish an integrated regulatory framework. This theoretical model systematically elucidates how microbial signals influence ovarian function through four core pathways: the hypothalamic-pituitary-ovarian (HPO) axis, metabolism and endocrine regulation, immunoregulation, and oxidative stress. Evaluating the efficacy of dietary modifications, probiotics, and microbiota transplantation in animal models and preliminary clinical studies will establish a robust theoretical foundation for developing microbiota-targeted innovative diagnostic and therapeutic strategies for POI, thereby enhancing reproductive health throughout the female lifespan.
- Open Access
Evolving tumor microenvironment: Driving cancer initiation and progression in cardiovascular diseases
- Open Access
Significance of non-steroidal anti-inflammatory drugs in the prevention and treatment of cervical cancer
- 11 March 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 117, 109774
Advances in the application of immune checkpoint inhibitors in gynecological tumors
- 11 March 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 117, 109774
Advances in the application of immune checkpoint inhibitors in gynecological tumors
- Open Access
- 15 September 2022
- Published by Springer Nature in Research Square
Fetuin B alleviates testosterone propionate-induced oxidative stress and mitochondrial dysfunction in KGN cells by upregulating the TGFR2/SMAD3 pathway
Background Polycystic ovary syndrome (PCOS) is one of the most common reproduction and endocrine disorders. Patients with abnormal follicle growth develop ovulation disorders and amenorrhea, and eventually infertility. The role of Fetuin-B (FETUB), one of the differentially expressed proteins (DEPs) in follicular fluid (FF) of PCOS patients, in pathogenesis of PCOS was not clearly clarified. Methods In this study, we performed iTRAQ-based quantitative proteomic analysis on FF collected from non-PCOS healthy controls and PCOS patients to identify DEPs. In addition, KGN cells treated with testosterone propionate (TP) were used as a model of hyperandrogenism in vitro to investigate the regulatory effects of the selected DEP, FETUB, on cellular processes in KGN cells and its molecular mechanism by detecting steroid hormone secretion, measuring indicators of oxidative stress (OS), mitochondria functions and apoptosis and characterizing the FETUB-altered downstream signaling. Results We found that supplementation with recombinant FETUB could significantly restore the total antioxidant capacity and activity of antioxidant enzymes, which were reduced by treatment with TP. Additionally, FETUB restored the secretory and mitochondrial functions in TP-impaired KGN cells and reduced their apoptosis. Furthermore, our study revealed that FETUB could bind with transforming growth factor beta receptor 2 (TGFR2) on the cell membrane of KGN cells and promote phosphorylation of SMAD3, which had a therapeutic effect against tissue injury and inflammation. And the protective effect of FETUB on TP-treated KGN cells was inhibited by pre-treatment with SB431542 and SIS3, selective inhibitors of TGFR2 and SMAD3, respectively. Conclusions These results indicate that FETUB may protect TP-treated KGN by alleviating OS and mitochondrial dysfunction via the TGFR2-mediated SMAD pathway. Data are available via ProteomeXchange with identifier PXD036531
- 15 September 2022
- Published by Springer Nature in Research Square
Open AccessFetuin B alleviates testosterone propionate-induced oxidative stress and mitochondrial dysfunction in KGN cells by upregulating the TGFR2/SMAD3 pathway
Background Polycystic ovary syndrome (PCOS) is one of the most common reproduction and endocrine disorders. Patients with abnormal follicle growth develop ovulation disorders and amenorrhea, and eventually infertility. The role of Fetuin-B (FETUB), one of the differentially expressed proteins (DEPs) in follicular fluid (FF) of PCOS patients, in pathogenesis of PCOS was not clearly clarified. Methods In this study, we performed iTRAQ-based quantitative proteomic analysis on FF collected from non-PCOS healthy controls and PCOS patients to identify DEPs. In addition, KGN cells treated with testosterone propionate (TP) were used as a model of hyperandrogenism in vitro to investigate the regulatory effects of the selected DEP, FETUB, on cellular processes in KGN cells and its molecular mechanism by detecting steroid hormone secretion, measuring indicators of oxidative stress (OS), mitochondria functions and apoptosis and characterizing the FETUB-altered downstream signaling. Results We found that supplementation with recombinant FETUB could significantly restore the total antioxidant capacity and activity of antioxidant enzymes, which were reduced by treatment with TP. Additionally, FETUB restored the secretory and mitochondrial functions in TP-impaired KGN cells and reduced their apoptosis. Furthermore, our study revealed that FETUB could bind with transforming growth factor beta receptor 2 (TGFR2) on the cell membrane of KGN cells and promote phosphorylation of SMAD3, which had a therapeutic effect against tissue injury and inflammation. And the protective effect of FETUB on TP-treated KGN cells was inhibited by pre-treatment with SB431542 and SIS3, selective inhibitors of TGFR2 and SMAD3, respectively. Conclusions These results indicate that FETUB may protect TP-treated KGN by alleviating OS and mitochondrial dysfunction via the TGFR2-mediated SMAD pathway. Data are available via ProteomeXchange with identifier PXD036531
- Open Access
- 8 February 2021
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (4) , 1
Ginkgo biloba leaf extract prevents diabetic nephropathy through the suppression of tissue transglutaminase
The present study aimed to investigate the preventive effects of Ginkgo biloba leaf extract (GBE) against extracellular matrix (ECM) accumulation in a streptozotocin (STZ)‑induced rat model of diabetic nephropathy (DN), and to determine its underlying molecular mechanism. In vivo, a rat model of DN was established by intraperitoneal injection of STZ, and the rats were subsequently administered GBE. The results demonstrated that GBE significantly decreased blood glucose, the urine protein excretion rate and ECM accumulation in DN rats. In addition, the development of DN significantly induced tissue transglutaminase (tTG) protein expression, which was detected by immunohistochemistry, western blotting and PCR analyses, while GBE administration decreased tTG expression in the diabetic kidney. In vitro, rat glomerular mesangial cells (HBZY‑1 cells) cultured with high glucose were also treated with GBE. The concentrations of tTG, fibronectin, type IV collagen, transforming growth factor (TGF)‑β and connective tissue growth factor (CTGF) were detected via ELISA. The results demonstrated that GBE notably decreased the concentration of these proteins, and tTG expression was positively associated with TGF‑β. GBE also suppressed tTG expression of high glucose‑treated HBZY‑1 cells in a concentration‑dependent manner. Furthermore, tTG protein expression was detected in high glucose‑treated HBZY‑1 cells transfected with small interfering RNA (siRNA) oligonucleotides against TGF‑β and CTGF to investigate a possible mechanism of GBE‑mediated inhibition of tTG. The results demonstrated that the tTG levels remained unchanged in CTGF siRNA‑transfected cells, but were decreased in the GBE + CTGF siRNA group compared with the control siRNA group, suggesting that tTG may not be regulated by CTGF, and the inhibitory effect of GBE on tTG may not be associated with the direct inhibition of CTGF. However, tTG expression was decreased following the transfection with TGF‑β siRNA, in which levels of tTG were similar compared with both the GBE group and GBE + TGF‑β siRNA group, indicating that tTG may be regulated by TGF‑β, and that the GBE‑induced repression of tTG expression may be associated with the downregulation of TGF‑β. Taken together, the results of the present study suggest that GBE prevented ECM accumulation by suppressing tTG expression in DN, which was predominantly mediated by TGF‑β.
- 8 February 2021
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (4) , 1
Open AccessGinkgo biloba leaf extract prevents diabetic nephropathy through the suppression of tissue transglutaminase
The present study aimed to investigate the preventive effects of Ginkgo biloba leaf extract (GBE) against extracellular matrix (ECM) accumulation in a streptozotocin (STZ)‑induced rat model of diabetic nephropathy (DN), and to determine its underlying molecular mechanism. In vivo, a rat model of DN was established by intraperitoneal injection of STZ, and the rats were subsequently administered GBE. The results demonstrated that GBE significantly decreased blood glucose, the urine protein excretion rate and ECM accumulation in DN rats. In addition, the development of DN significantly induced tissue transglutaminase (tTG) protein expression, which was detected by immunohistochemistry, western blotting and PCR analyses, while GBE administration decreased tTG expression in the diabetic kidney. In vitro, rat glomerular mesangial cells (HBZY‑1 cells) cultured with high glucose were also treated with GBE. The concentrations of tTG, fibronectin, type IV collagen, transforming growth factor (TGF)‑β and connective tissue growth factor (CTGF) were detected via ELISA. The results demonstrated that GBE notably decreased the concentration of these proteins, and tTG expression was positively associated with TGF‑β. GBE also suppressed tTG expression of high glucose‑treated HBZY‑1 cells in a concentration‑dependent manner. Furthermore, tTG protein expression was detected in high glucose‑treated HBZY‑1 cells transfected with small interfering RNA (siRNA) oligonucleotides against TGF‑β and CTGF to investigate a possible mechanism of GBE‑mediated inhibition of tTG. The results demonstrated that the tTG levels remained unchanged in CTGF siRNA‑transfected cells, but were decreased in the GBE + CTGF siRNA group compared with the control siRNA group, suggesting that tTG may not be regulated by CTGF, and the inhibitory effect of GBE on tTG may not be associated with the direct inhibition of CTGF. However, tTG expression was decreased following the transfection with TGF‑β siRNA, in which levels of tTG were similar compared with both the GBE group and GBE + TGF‑β siRNA group, indicating that tTG may be regulated by TGF‑β, and that the GBE‑induced repression of tTG expression may be associated with the downregulation of TGF‑β. Taken together, the results of the present study suggest that GBE prevented ECM accumulation by suppressing tTG expression in DN, which was predominantly mediated by TGF‑β.